Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
04 nov. 2024 06h55 HE
|
Profound Medical Corp.
– TULSA to stand above all other covered prostate disease treatment modalities at Urology Level 7 reimbursement – – First-time CPT® code reimbursement for TULSA to be effective...
$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment
10 oct. 2024 10h00 HE
|
Unyte Health
The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
11 juil. 2024 07h00 HE
|
Profound Medical Corp.
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
10 avr. 2024 08h00 HE
|
ProPhase Labs, Inc.
Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its...
HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT
23 janv. 2024 09h00 HE
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions, announced FFRCT was transitioned to a...
Infectious Disease Diagnostics Market Size (Product, Technology) - Reach $59.95 Billion by 2030 at 5.7% CAGR with Veterinary Segment Driving Growth During 2022 to 2030 | The Insight Partners
08 nov. 2023 02h04 HE
|
The Insight Partners
Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organism species. Infectious disease diagnostics are...
Endonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical Products
25 avr. 2022 09h08 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, April 25, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:ENDV) today announced an agreement with NAMSA – a leading Global Contract Research Organization (CRO) and...
Oculogica Announces New Category 3 CPT Code Created by American Medical Association
29 oct. 2019 07h45 HE
|
Oculogica, Inc.
NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics for brain health, announced today that the American Medical Association (AMA) has...
AMA Enhances Genetic Testing Registry
17 janv. 2013 12h09 HE
|
American Medical Association
CHICAGO, Jan. 17, 2013 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) announced an agreement with the National Library of Medicine that will enhance the National Institutes of Health's...